Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WAIMATSS minocycline plus tPA for ischaemic stroke
ACTRN12611001053910Phase 2Recruiting
- Sponsor
- Sir Charles Gairdner Hospital
- Start
- Nov 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of minocycline and tissue-plasminogen activator in brain infarction, sponsored by Sir Charles Gairdner Hospital. Primary endpoint: Any intracranial haemorrhage on follow-up CT. Started Nov 2011; status: recruiting.
02
Drugs
minocyclinetissue-plasminogen activator
03
Conditions
brain infarction
Beyond the preview
Go deeper on ACTRN12611001053910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001053910.